Tokyo Tape
Sign in
← Kaken Pharmaceutical

Quarterly report · Q1

4521.TEDINET S100RKL3
Period2023-04-01 → 2023-06-30
Filed2023-08-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥18.1bn2023-04-01 → 2023-06-30Cons.Net sales
Revenue¥73.0bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥18.2bn2022-04-01 → 2022-06-30Cons.Net sales
Operating income¥3.3bn2023-04-01 → 2023-06-30Cons.Operating income
Operating income¥4.1bn2022-04-01 → 2022-06-30Cons.Operating income
Ordinary income¥3.5bn2023-04-01 → 2023-06-30Cons.Ordinary income
Ordinary income¥8.7bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥4.3bn2022-04-01 → 2022-06-30Cons.Ordinary income
Profit before tax¥3.5bn2023-04-01 → 2023-06-30Cons.Income before income taxes
Profit before tax¥4.0bn2022-04-01 → 2022-06-30Cons.Income before income taxes
Net income (owners)¥2.5bn2023-04-01 → 2023-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥5.4bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥2.9bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income¥2.5bn2023-04-01 → 2023-06-30Cons.Profit loss
Net income¥2.9bn2022-04-01 → 2022-06-30Cons.Profit loss
Total assets¥167.2bnat 2023-06-30Cons.Assets
Total assets¥166.3bnat 2023-03-31Cons.Assets
Total assets¥165.1bnat 2022-06-30Cons.Total assets (5-year summary)
Total liabilities¥29.3bnat 2023-06-30Cons.Liabilities
Total liabilities¥29.5bnat 2023-03-31Cons.Liabilities
Net assets / equity¥137.8bnat 2023-06-30Cons.Net assets
Net assets / equity¥136.8bnat 2023-03-31Cons.Net assets
Net assets / equity¥137.9bnat 2022-06-30Cons.Net assets (5-year summary)
Cash and deposits¥56.8bnat 2023-06-30Cons.Cash and deposits
Cash and deposits¥59.6bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥66.992023-04-01 → 2023-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥144.82022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥76.912022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio82.1%at 2023-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio81.9%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio83.1%at 2022-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
jpcrp040300-q1r_E00935-000Medicinereportable segmentrevenue2023-04-01 → 2023-06-30¥17.5bn
jpcrp040300-q1r_E00935-000Medicinereportable segmentrevenue external2023-04-01 → 2023-06-30¥17.5bn
jpcrp040300-q1r_E00935-000Medicinereportable segmentsegment profit2023-04-01 → 2023-06-30¥3.0bn
jpcrp040300-q1r_E00935-000Real Estatereportable segmentrevenue2023-04-01 → 2023-06-30¥605m
jpcrp040300-q1r_E00935-000Real Estatereportable segmentrevenue external2023-04-01 → 2023-06-30¥605m
jpcrp040300-q1r_E00935-000Real Estatereportable segmentsegment profit2023-04-01 → 2023-06-30¥321m
—segment totalrevenue2023-04-01 → 2023-06-30¥18.1bn
—segment totalrevenue external2023-04-01 → 2023-06-30¥18.1bn
—segment totalsegment profit2023-04-01 → 2023-06-30¥3.3bn
jpcrp040300-q1r_E00935-000Medicinereportable segmentrevenue2022-04-01 → 2022-06-30¥17.6bn
jpcrp040300-q1r_E00935-000Medicinereportable segmentrevenue external2022-04-01 → 2022-06-30¥17.6bn
jpcrp040300-q1r_E00935-000Medicinereportable segmentsegment profit2022-04-01 → 2022-06-30¥3.8bn
jpcrp040300-q1r_E00935-000Real Estatereportable segmentrevenue2022-04-01 → 2022-06-30¥615m
jpcrp040300-q1r_E00935-000Real Estatereportable segmentrevenue external2022-04-01 → 2022-06-30¥615m
jpcrp040300-q1r_E00935-000Real Estatereportable segmentsegment profit2022-04-01 → 2022-06-30¥295m
—segment totalrevenue2022-04-01 → 2022-06-30¥18.2bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥18.2bn
—segment totalsegment profit2022-04-01 → 2022-06-30¥4.1bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 374
ItemContextValueUnit
Number of shares held in own name treasury shares etcCurrentQuarterInstant8433300
Number of shares held in others names treasury shares etcCurrentQuarterInstant－
Total number of shares held treasury shares etcCurrentQuarterInstant8433300
Shareholding ratio treasury shares etcCurrentQuarterInstant0.1836
Cash and depositsPrior1YearInstant59561000000JPY
Cash and depositsCurrentQuarterInstant56835000000JPY
Notes and accounts receivable trade and contract assetsPrior1YearInstant19268000000JPY
Notes and accounts receivable trade and contract assetsCurrentQuarterInstant20163000000JPY
Short term investment securitiesPrior1YearInstant14699000000JPY
Short term investment securitiesCurrentQuarterInstant14699000000JPY
Merchandise and finished goodsPrior1YearInstant6734000000JPY
Merchandise and finished goodsCurrentQuarterInstant7383000000JPY
Work in processPrior1YearInstant2481000000JPY
Work in processCurrentQuarterInstant2421000000JPY
Raw materials and suppliesPrior1YearInstant6348000000JPY
Raw materials and suppliesCurrentQuarterInstant7029000000JPY
Other caPrior1YearInstant809000000JPY
Other caCurrentQuarterInstant785000000JPY
Allowance for doubtful accounts caPrior1YearInstant-0JPY
Allowance for doubtful accounts caCurrentQuarterInstant-0JPY
Current assetsPrior1YearInstant109903000000JPY
Current assetsCurrentQuarterInstant109318000000JPY
Buildings and structures netPrior1YearInstant16433000000JPY
Buildings and structures netCurrentQuarterInstant16196000000JPY
Other net ppePrior1YearInstant9064000000JPY
Other net ppeCurrentQuarterInstant8859000000JPY
Property plant and equipmentPrior1YearInstant25498000000JPY
Property plant and equipmentCurrentQuarterInstant25055000000JPY
In process research and development iaPrior1YearInstant5800000000JPY
In process research and development iaCurrentQuarterInstant5800000000JPY
Other iaPrior1YearInstant941000000JPY
Other iaCurrentQuarterInstant966000000JPY
Intangible assetsPrior1YearInstant6741000000JPY
Intangible assetsCurrentQuarterInstant6766000000JPY
Investment securitiesPrior1YearInstant17511000000JPY
Investment securitiesCurrentQuarterInstant19382000000JPY
Other ioaPrior1YearInstant6674000000JPY
Other ioaCurrentQuarterInstant6627000000JPY
Investments and other assetsPrior1YearInstant24185000000JPY
Investments and other assetsCurrentQuarterInstant26010000000JPY
Noncurrent assetsPrior1YearInstant56425000000JPY
Noncurrent assetsCurrentQuarterInstant57832000000JPY
AssetsPrior1YearInstant166328000000JPY
AssetsCurrentQuarterInstant167151000000JPY
Notes and accounts payable tradePrior1YearInstant6130000000JPY
Notes and accounts payable tradeCurrentQuarterInstant7072000000JPY
Electronically recorded obligations operating clPrior1YearInstant89000000JPY
Electronically recorded obligations operating clCurrentQuarterInstant126000000JPY
Short term loans payablePrior1YearInstant3850000000JPY
Short term loans payableCurrentQuarterInstant3850000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass rounding
balance sheet identityconsolidated 2023-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass